Midline catheter for outpatient lidocaine infusion series
Outpatient Midline Catheter in Patients Receiveing Lidocaine Infusion Therapy. A Prospective, Observational Study.
This project will test if using a midline catheter makes repeated outpatient lidocaine infusions for adults with chronic pain safer and more comfortable.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 500 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Medical University of Warsaw Academic / other |
| Locations | 1 site (Warsaw) |
| Trial ID | NCT07555314 on ClinicalTrials.gov |
What this trial studies
This observational study will enroll adults who require serial intravenous lidocaine infusions for chronic pain and deliver ten outpatient infusions through a midline catheter. Investigators will collect data on catheter-related complications, infusion delivery success, patient comfort, and practical aspects of placement and maintenance. No experimental drug or randomization is involved; standard lidocaine infusion protocols will be followed while monitoring device performance and adverse events. Outcomes will include safety signals, feasibility metrics, and patient-reported experience with the midline device.
Who should consider this trial
Good fit: Adults (≥18 years) who are candidates for serial outpatient intravenous lidocaine infusions for chronic pain and can give informed consent are eligible.
Not a fit: Patients who do not require repeated IV lidocaine infusions, who cannot consent, or who have contraindications to midline catheter placement are unlikely to benefit.
Why it matters
Potential benefit: If successful, this approach could make serial lidocaine infusions easier to deliver in outpatient settings with fewer placement attempts and improved patient comfort.
How similar studies have performed: Midline catheters have been used for repeated peripheral infusions in other medical contexts, but there is limited published data specifically on serial lidocaine treatment for chronic pain, so the approach is partially supported but not extensively tested.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients qualified for lidocaine infusion therapy due to the chronic pain * Able to provide consent * ≥18 years of age Exclusion Criteria: * Lack of patient consent
Where this trial is running
Warsaw
- Szpital Kliniczny Dzieciątka Jezus — Warsaw, Poland (Recruiting)
Study contacts
- Study coordinator: Piotr Mieszczański, MD
- Email: piotr.mieszczanski@wum.edu.pl
- Phone: +48225021721
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.